Pacific Biosciences of California, Inc. (PACB) , popularly known as PacBio, delivered an adjusted loss per share of 26 cents in first-quarter 2024, narrower than the year-ago loss of 31 cents per share. The adjusted loss per share aligned with the Zacks Consensus Estimate. The company’s GAAP loss per share was 29 cents in the quarter, narrower than the year-ago period’s loss of 36 cents. Revenues in Detail PacBio registered revenues of $38.8 million in the first quarter, down 0.2% year over year. The figure ...